# Larimar Therapeutics, Inc.: Form 8-K, filed May 31, 2024

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2024-05-31
- Accepted by EDGAR: May 31, 2024, 20:07 ET
- Period: 2024-05-29
- Accession: 0000950170-24-067306
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000095017024067306/lrmr-20240529.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000095017024067306/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000095017024067306/lrmr-20240529.htm

Filed May 31, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-067306. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.